GlassScriptPhysician profile
Phina A Mayu
NPI 1003383795
$2,263.15
in general payments reported to CMS, 2019-2025
8 companies · $1,314 in 2025
The $1,314 reported for 2025 was more than what 88% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.56 · 2022: $208 · 2023: $279 · 2024: $449 · 2025: $1,314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,189 · Food and Beverage: $853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,189.19 |
| Food and Beverage | $852.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuronetics, INC. | $1,313.70 | 2025 | Neurostar Tms Therapy System |
| Otsuka America Pharmaceutical, INC. | $227.08 | 2022-2024 | Abilify Asimtufii, Abilify Maintena |
| Gilead Sciences, INC. | $220.69 | 2022-2023 | Descovy |
| Abbvie INC. | $150.40 | 2021-2024 | |
| Teva Pharmaceuticals USA, INC. | $115.47 | 2023 | Austedo Xr |
| Neurocrine Biosciences, INC. | $95.85 | 2024 | Ingrezza |
| Janssen Pharmaceuticals, INC | $93.38 | 2024 | Invega Sustenna |
| Phathom Pharmaceuticals, INC. | $46.58 | 2023 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phina Mayu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.